The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Treatment for Classical Hodgkin Lymphoma in Children and Adolescents
Official Title: An International, Multicentre, Randomised Controlled Trial. Treatment for Classical Hodgkin Lymphoma in Children and Adolescents Standard Treatment (Chemotherapy and RT) Compared With Experimental Treatment (Chemotherapy Without RT or Restricted to RT)
Study ID: NCT02797717
Brief Summary: Reduction of the indication for radiotherapy (RT) in newly diagnosed patients with classical Hodgkins lymphoma without compromising cure rates. Investigation of a chemotherapy intensification randomisation in intermediate and advanced classical Hodgkins lymphoma patients to compensate for reduction in RT.
Detailed Description:
Minimum Age: 1 Month
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Schneider children's medical center, Petach-Tikva, , Israel
Name: Dieter K.rholz, Prof. Dr.
Affiliation: Universit.tsklinikum Giessen
Role: STUDY_CHAIR
Name: Galia Avrahami, MD
Affiliation: Schneider children medical center,Kaplan 14 Petach-Tikva,Israel
Role: PRINCIPAL_INVESTIGATOR